Xconomy National

Archives

by in
Entry Author Date Location
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall Luke Timmerman 01/27/12 Boston
Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls Luke Timmerman 01/03/12 Boston
Aastrom Reports Positive Phase 2 Trial Results Sarah Schmid 11/15/11 Detroit
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News Erin Kutz 11/11/11 Boston
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic Luke Timmerman 09/21/11 Seattle
Mascoma Seeks IPO, Tokai Takes in $23M, Boston-Power Gets $125 for Shift to China, & More Boston-Area Deals News Erin Kutz 09/21/11 Boston
Zogenix Pain Drug Meets Endpoint Bruce V. Bigelow 08/17/11 San Diego
AVI Starts Duchenne Trial Luke Timmerman 08/15/11 Seattle
Meritage Pharma Passes Key Test With Drug to Reduce Swelling of the Food Pipe Luke Timmerman 05/10/11 San Diego
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate Ryan McBride 04/20/11 Boston
Sangart Gets $50M Infusion for Oxygen-Carrying Blood Adjunct Bruce V. Bigelow 04/19/11 San Diego
Gilead Drug Fails AIDS Prevention Trial Luke Timmerman 04/18/11 San Francisco
Biotech’s Missed Opportunity: Small-Town and Rural America Luke Timmerman 04/18/11 National
Public Policy Institute on How to Boost Biotech in New York: More Jobs, Better Teamwork, Fewer Taxes Arlene Weintraub 04/12/11 New York
Biogen Idec Passes Pivotal Trial With Oral MS Drug; Shares Climb Luke Timmerman 04/11/11 Boston
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News Luke Timmerman 04/07/11 Seattle
Tolerx and Glaxo Diabetes Drug Disappoints in Late-Stage Study Ryan McBride 03/11/11 Boston
RXi Sells Stock and Warrants, Cardiorobotics Raises $6.6M, ImmunoGen Dishes On New Drugs, & More Boston-Area Life Sciences News Erin Kutz 03/04/11 Boston
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News Erin Kutz 02/25/11 Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug Luke Timmerman 02/23/11 Boston
Jennerex, Maker of Cancer-Fighting Virus, Says Early Data Shows Survival Benefit Luke Timmerman 02/17/11 San Francisco
Stromedix Chief, After Reloading the Company Treasury, Sets Sight on Trial for Deadly Lung Disease Ryan McBride 02/07/11 Boston
Clinical Data Stock Surging on FDA Approval of Anti-Depression Drug Ryan McBride 01/24/11 Boston
Plexxikon, Roche Drug Extends Lives in Patients With Deadly Skin Cancer Luke Timmerman 01/19/11 San Francisco
Ariad Pharma Stock Up More than 25 Percent on Positive Phase III Data Ryan McBride 01/18/11 Boston
Allon Starts Trial for Brain Disease Luke Timmerman 01/06/11 Seattle
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients Ryan McBride 12/10/10 Boston
Seattle Genetics, Millennium’s Encore: Souped-Up Antibody Looks Better in 2nd Trial Luke Timmerman 12/07/10 Seattle
Glaxo Ends Resveratrol Drug Study Ryan McBride 12/01/10 Boston
Pearl Therapeutics, Fresh Off Big VC Round, Tops $3B Lung Drug in Head-to-Head Trial Luke Timmerman 12/01/10 San Francisco
Page 1 of 8 next page »
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.